These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31227392)

  • 21. Six months follow-up of protected high-risk percutaneous coronary intervention with the microaxial Impella pump: results from the German Impella registry.
    Baumann S; Werner N; Al-Rashid F; Schäfer A; Bauer T; Sotoudeh R; Bojara W; Shamekhi J; Sinning JM; Becher T; Eder F; Akin I
    Coron Artery Dis; 2020 May; 31(3):237-242. PubMed ID: 31658135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group.
    Doshi R; Patel K; Decter D; Jauhar R; Meraj P
    Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S90-S95. PubMed ID: 30122245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term survival after early unloading with Impella CP
    Loehn T; O'Neill WW; Lange B; Pfluecke C; Schweigler T; Mierke J; Waessnig N; Mahlmann A; Youssef A; Speiser U; Strasser RH; Ibrahim K
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):149-157. PubMed ID: 30456984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock.
    Helgestad OKL; Josiassen J; Hassager C; Jensen LO; Holmvang L; Udesen NLJ; Schmidt H; Berg Ravn H; Moller JE
    Open Heart; 2020; 7(1):e001214. PubMed ID: 32201591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonemergent Percutaneous Coronary Intervention on an Unprotected Left Main Coronary Artery Supported with Impella® Heart Pump in Patients Ineligible for Surgical Revascularization.
    Meraj PM; Dixon S; Moses J; Ibrahim K; Schäfer A; Akin I; Hill J; Schreiber T; O'Neill WW
    J Interv Cardiol; 2019; 2019():9691753. PubMed ID: 31772553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous Ventricular Assist Devices: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2017; 17(2):1-97. PubMed ID: 28232854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Impella Support in Postcardiac Arrest Cardiogenic Shock Complicating Acute Myocardial Infarction Improves Short- and Long-Term Survival.
    Chatzis G; Markus B; Luesebrink U; Ahrens H; Divchev D; Syntila S; Scheele N; Al Eryani H; Tousoulis D; Schieffer B; Karatolios K
    Crit Care Med; 2021 Jun; 49(6):943-955. PubMed ID: 33729726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of in-Hospital Left Ventricular Ejection Fraction Recovery on Long-Term Outcomes in Patients Who Underwent Impella Support for HR PCI or Cardiogenic Shock: A Sub-Analysis from the IMP-IT Registry.
    Iannaccone M; Franchin L; Burzotta F; Botti G; Pazzanese V; Briguori C; Trani C; Piva T; De Marco F; Masiero G; Di Biasi M; Pagnotta P; Casu G; Scandroglio AM; Tarantini G; Chieffo A
    J Pers Med; 2023 May; 13(5):. PubMed ID: 37240996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of a pulsatile and a continuous flow left ventricular assist device in high-risk PCI.
    Samol A; Wiemer M; Kaese S
    Int J Cardiol; 2022 Aug; 360():7-12. PubMed ID: 35597491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impella-assisted chronic total occlusion percutaneous coronary interventions: A multicenter retrospective analysis.
    Riley RF; McCabe JM; Kalra S; Lazkani M; Pershad A; Doshi D; Kirtane AJ; Nicholson W; Kearney K; Demartini T; Aaron Grantham J; Moses J; Lombardi W; Karmpaliotis D
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):1261-1267. PubMed ID: 30019817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
    Schreiber T; Wah Htun W; Blank N; Telila T; Mercado N; Briasoulis A; Kaki A; Kondur A; Munir A; Grines C
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):576-581. PubMed ID: 28417594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indication and short-term clinical outcomes of high-risk percutaneous coronary intervention with microaxial Impella® pump: results from the German Impella® registry.
    Baumann S; Werner N; Ibrahim K; Westenfeld R; Al-Rashid F; Sinning JM; Westermann D; Schäfer A; Karatolios K; Bauer T; Becher T; Akin I
    Clin Res Cardiol; 2018 Aug; 107(8):653-657. PubMed ID: 29520699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility and efficacy of the 2.5 L and 3.8 L impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis.
    Spiro J; Venugopal V; Raja Y; Ludman PF; Townend JN; Doshi SN
    Catheter Cardiovasc Interv; 2015 May; 85(6):981-9. PubMed ID: 24408882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience.
    Cohen MG; Matthews R; Maini B; Dixon S; Vetrovec G; Wohns D; Palacios I; Popma J; Ohman EM; Schreiber T; O'Neill WW
    Am Heart J; 2015 Nov; 170(5):872-9. PubMed ID: 26542494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of Impella 2.5 use in patients undergoing Percutaneous Coronary Intervention in Henan, China: a case series.
    Bhat RA; Ali SM; Rathi A; Bhat JA; Iqbal RS; Islam MM; Maqbool S; Tibrewal A; Qu Y; Zhang Y; Sun Y; Xiao W; Gao C
    Perfusion; 2023 Jan; 38(1):208-213. PubMed ID: 34581607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic Support With a Microaxial Percutaneous Left Ventricular Assist Device (Impella) Protects Against Acute Kidney Injury in Patients Undergoing High-Risk Percutaneous Coronary Intervention.
    Flaherty MP; Pant S; Patel SV; Kilgore T; Dassanayaka S; Loughran JH; Rawasia W; Dawn B; Cheng A; Bartoli CR
    Circ Res; 2017 Feb; 120(4):692-700. PubMed ID: 28073804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Impella Recover 2.5 and TandemHeart ventricular assist devices are safe and associated with equivalent clinical outcomes in patients undergoing high-risk percutaneous coronary intervention.
    Kovacic JC; Nguyen HT; Karajgikar R; Sharma SK; Kini AS
    Catheter Cardiovasc Interv; 2013 Jul; 82(1):E28-37. PubMed ID: 21234916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics and outcomes of patients requiring prolonged mechanical circulatory support after high-risk percutaneous coronary intervention.
    Min S; Basir MB; Lemor A; Zhou Z; Abu-Much A; Redfors B; Thompson JB; Truesdell AG; Bharadwaj AS; Li Y; Kaki A; Brott BC; Wohns DH; Meraj PM; Daggubati R; Grines CL; O'Neill WW; Moses JW
    EuroIntervention; 2024 Jan; 20(2):e135-e145. PubMed ID: 38224254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry.
    Maini B; Naidu SS; Mulukutla S; Kleiman N; Schreiber T; Wohns D; Dixon S; Rihal C; Dave R; O'Neill W
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):717-25. PubMed ID: 22105829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Outcomes of Percutaneous Coronary Intervention on Native Coronary Arteries Versus on Saphenous Venous Aorta Coronary Conduits in Patients With Low Left Ventricular Ejection Fraction and Impella Device Implantation Achieved or Attempted (from the PROTECT II Randomized Trial and the cVAD Registry).
    Shavelle DM; Banerjee S; Maini B; Schreiber TL; Kapasi N; O'Neill WW; Popma J; Matthews RV
    Am J Cardiol; 2018 Sep; 122(6):966-972. PubMed ID: 30057231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.